SPHDF (Santhera Pharmaceuticals Holding AG) Change In Inventory: $0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SPHDF Santhera Pharmaceuticals Holding AG SPHDF
39 GF Score
Price $23.25
GF Value $35.65
! 6 Warning Signs
View Full Analysis

What is Santhera Pharmaceuticals Holding AG Change In Inventory?

Santhera Pharmaceuticals Holding AG SPHDF 39 Change In Inventory is $0.00 Mil as of Dec. 2025. GuruFocus rates SPHDF with a GF Score™ of 39/100 and a GF Value™ of $35.65. The stock has 6 warning signs investors should review.

Santhera Pharmaceuticals Holding AG's change in inventory for the quarter that ended in Dec. 2025 was $0.00 Mil. It means Santhera Pharmaceuticals Holding AG's inventory stayed the same from Jun. 2025 to Dec. 2025 .

Santhera Pharmaceuticals Holding AG's change in inventory for the fiscal year that ended in Dec. 2025 was $0.00 Mil. It means Santhera Pharmaceuticals Holding AG's inventory stayed the same from Dec. 2024 to Dec. 2025 .

Santhera Pharmaceuticals Holding AG's Total Inventories for the quarter that ended in Dec. 2025 was $31.21 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Santhera Pharmaceuticals Holding AG's Days Inventory for the quarter that ended in Dec. 2025 was 153.80.

Inventory Turnover measures how fast the company turns over its inventory within a year. Santhera Pharmaceuticals Holding AG's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.19.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Santhera Pharmaceuticals Holding AG's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.47.

Santhera Pharmaceuticals Holding AG  (OTCPK:SPHDF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Santhera Pharmaceuticals Holding AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=31.6075/37.506*365 / 2
=153.80

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Santhera Pharmaceuticals Holding AG's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=37.506 / 31.6075
=1.19

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Santhera Pharmaceuticals Holding AG's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=31.6075 / 66.724
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santhera Pharmaceuticals Holding AG Change In Inventory Related Terms

Santhera Pharmaceuticals Holding AG Change In Inventory Historical Data

* Premium members only.

The historical data trend for Santhera Pharmaceuticals Holding AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santhera Pharmaceuticals Holding AG Change In Inventory Chart

Santhera Pharmaceuticals Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Santhera Pharmaceuticals Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SPHDF
39GF Score
Santhera Pharmaceuticals Holding AG SPHDF
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santhera Pharmaceuticals Holding AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.00 Mil mean?
Santhera Pharmaceuticals Holding AG (SPHDF) has a Change In Inventory of $0.00 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Santhera Pharmaceuticals Holding AG and its competitors.
Is Santhera Pharmaceuticals Holding AG's Change In Inventory too high?
Santhera Pharmaceuticals Holding AG's current Change In Inventory is $0.00 Mil. Overall, Santhera Pharmaceuticals Holding AG has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Santhera Pharmaceuticals Holding AG's Change In Inventory compare to VRTX and REGN?
Santhera Pharmaceuticals Holding AG's Change In Inventory of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Santhera Pharmaceuticals Holding AG and its competitors. Santhera Pharmaceuticals Holding AG's current Change In Inventory is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santhera Pharmaceuticals Holding AG stock overvalued right now?
Santhera Pharmaceuticals Holding AG (SPHDF) has a current Change In Inventory of $0.00 Mil. The stock's GF Value™ is $35.65, compared to a current price of $23.25 — trading 34.8% below its estimated fair value. The current Change In Inventory is $0.00 Mil. Santhera Pharmaceuticals Holding AG's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Santhera Pharmaceuticals Holding AG (SPHDF), the current Change In Inventory is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santhera Pharmaceuticals Holding AG (SPHDF) Overvalued in 2026?

Based on GuruFocus' analysis, Santhera Pharmaceuticals Holding AG stock appears to be undervalued. The current stock price of $23.25 is trading 34.8% below its estimated GF Value™ of $35.65.

Key valuation signals for SPHDF:

  • Change In Inventory: $0.00 Mil
  • GF Value™: $35.65 vs. price of $23.25 (34.8% below fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the SPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santhera Pharmaceuticals Holding AG Business Description

Address Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company committed to developing and commercializing medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs. It is focused on the development of treatments for pulmonary and neuromuscular diseases that currently lack treatment options. The company is currently engaged in the rollout of its AGAMREE (vamorolone) medicine for the treatment of Duchenne muscular dystrophy (DMD) globally. Santhera has one operating segment, namely the development and commercialization of products for the treatment of neuromuscular diseases. Geographically, the company generates maximum revenue from Europe, and the rest from Asia and North America.
39GF Score

Get the complete analysis for SPHDF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.25
Price
$35.65
GF Value